Start Your Risk-Free Subscription

Login

The Daily Biopharmaceutical News Source

Advanced Search

BioWorld-International-2002-02-20

Microscience Completes £25.5M Round, Plans Clinical Programs

Alizyme Receives Approval For Phase III Trial Of Colal-Pred

By Nuala Moran

Wednesday, February 20, 2002

No Abstract

»

Login or register to post comments
Read more

LION Streamlining Operations, Eliminating About 80 Positions

By Rainer B. Langen

Wednesday, February 20, 2002

No Abstract

»

Login or register to post comments
Read more

EU Commissioner Continues Push For Changes In Policy

By Peter O’Donnell

Wednesday, February 20, 2002

No Abstract

»

Login or register to post comments
Read more

HiberGen Raises EUR3.8M In Follow-On Funding From Trinity

By Cormac Sheridan

Wednesday, February 20, 2002

No Abstract

»

Login or register to post comments
Read more

Other News To Note

Wednesday, February 20, 2002

No Abstract

»

Login or register to post comments
Read more

Oxagen, Insmed Enter Alliance On Polycystic Ovary Syndrome

By Nuala Moran

Wednesday, February 20, 2002

No Abstract

»

Login or register to post comments
Read more

Arrow Raises £7M In Second Round For Anti-Infectives Work

By Nuala Moran

Wednesday, February 20, 2002

No Abstract

»

Login or register to post comments
Read more

Australian Researchers Isolate Gene Implicated In Hay Fever

By Mark Lawson

Wednesday, February 20, 2002

No Abstract

»

Login or register to post comments
Read more

Sanofi-Synthélabo Selects Melanoma Vaccine From IDM

By James Etheridge

Wednesday, February 20, 2002

No Abstract

»

Login or register to post comments
Read more

Microscience Completes £25.5M Round, Plans Clinical Programs

By Nuala Moran

Wednesday, February 20, 2002

LONDON - Microscience Ltd. raised £25.5 million (US$36.3 million) in a third-round funding, enabling it to put five infectious disease vaccines into clinical trials this year and develop them through to Phase IIb. (BioWorld International)

»

Login or register to post comments
Read more

Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST

BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA

Part of Thompson Media Group LLC
Thompson.com | Sheshunoff.com | ASPratt.com | AHCMedia.com | BioWorld.com | CMEweb.com | ThePerformanceInstitute.org | ASMIweb.com

Editorial Guidelines

For Site License Discounts, please contact Customer Service at (800) 477-6307 or customerservice@bioworld.com.